Literature DB >> 2495911

How to select patients with deep vein thrombosis for tPA therapy.

W D Brown1, S Z Goldhaber.   

Abstract

Despite enthusiasm for using thrombolytic therapy to treat proximal deep venous thrombosis (DVT), the proportion of patients eligible for this therapeutic strategy is unknown. Therefore, we screened all patients at Brigham and Women's Hospital who underwent leg venography in 1987. Of 240 patients with suspected DVT, 87 (36%) had positive venograms. Of those with positive venograms, 72 (83%) had proximal DVT, and 15 (17%) had DVT limited to calf veins. Overall, 22% of patients with proximal DVT were eligible for thrombolytic therapy. The major exclusion criteria were: (1) recent trauma or surgery, (2) recent GI bleeding, and (3) history of a bleeding disorder. Thus, thrombolytic therapy could be given to approximately one-fifth of our patients with proximal DVT.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495911     DOI: 10.1378/chest.95.5_supplement.276s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Paget-Schrotter syndrome and complications of management.

Authors:  A Dep; E Concannon; S M Mc Hugh; P Burke
Journal:  BMJ Case Rep       Date:  2013-07-12

Review 2.  Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.

Authors:  A J Wagstaff; J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

3.  Upper extremity deep vein thrombosis.

Authors:  Sanjith Saseedharan; Sunil Bhargava
Journal:  Int J Crit Illn Inj Sci       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.